Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China flag China · Delayed Price · Currency is CNY
26.54
-0.16 (-0.60%)
At close: Jul 15, 2025, 2:57 PM CST
44.87%
Market Cap1.50B
Revenue (ttm)232.86M
Net Income (ttm)-12.94M
Shares Out55.19M
EPS (ttm)-0.23
PE Ration/a
Forward PE108.44
Dividendn/a
Ex-Dividend Daten/a
Volume784,079
Average Volume1,043,055
Open26.53
Previous Close26.70
Day's Range25.93 - 26.70
52-Week Range12.38 - 27.63
Beta0.24
RSI67.88
Earnings DateAug 29, 2025

About SHA:688217

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases. It provides self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. The company was founded in 2012 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 401
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688217
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.